A senior healthcare analyst at Bernstein this morning reiterated UnitedHealth as one of his two top stock picks for the early 2026 investing cycle. He cited a projected outperform in both the core insurance business and the growing Optum platform, noting that UnitedHealth’s combined medical loss ratio has improved by 150 basis points since Q2 2025. The analyst raised his 12-month price target by 3.5%, reflecting stronger-than-expected membership growth in Medicare Advantage and a 12% year-over-year increase in Optum Health revenue during the third quarter.

In response to the fatal workplace shooting at its Minnetonka headquarters last year, UnitedHealth has ramped up spending on executive protection and facility hardening. The company allocated $48 million to its 2025 security budget—up 120% from 2024—covering biometric access controls, perimeter surveillance upgrades, and a dedicated executive protection team. UnitedHealth’s chief security officer reports that employee training programs have expanded to cover active-shooter response for 15,000 staff members across 50 sites nationwide.

Over the trailing twelve months, UnitedHealth’s stock has declined by 34.5% as rising medical costs and margin compression weighed on earnings. The company reported a year-end medical cost ratio of 83.1%, up from 80.2% a year earlier, driven by higher specialty drug spending and increased hospital admissions. Investors will be watching the Q4 earnings release, scheduled for early February, for updated guidance on 2026 operating margins and any commentary on anticipated cost management initiatives.